Fresenius SE & Co KGaA (FRE) Given a €50.00 Price Target by Credit Suisse Group Analysts

Credit Suisse Group set a €50.00 ($58.14) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Monday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

FRE has been the subject of a number of other reports. Jefferies Financial Group set a €53.00 ($61.63) price objective on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Thursday, March 7th. Berenberg Bank set a €70.95 ($82.50) price objective on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Wednesday, April 24th. HSBC set a €55.00 ($63.95) price objective on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Wednesday, February 13th. UBS Group set a €46.00 ($53.49) price objective on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Monday, February 11th. Finally, Goldman Sachs Group set a €52.00 ($60.47) price objective on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Monday, February 25th. Ten equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has a consensus rating of Buy and a consensus price target of €59.29 ($68.94).

Shares of Fresenius SE & Co KGaA stock opened at €51.74 ($60.16) on Monday. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

See Also: Investing strategies using the yield curve

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.